Security Snapshot

Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) Institutional Ownership

CUSIP: 13463J101

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

39

Shares (Excl. Options)

38,247,378

Price

$6.13

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
CAMP on Nasdaq
Shares outstanding
51,990,875
Price per share
$4.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
38,247,378
Total reported value
$234,599,194
% of total 13F portfolios
0%
Share change
+8,053,354
Value change
+$51,453,984
Number of holders
39
Price from insider filings
$4.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share is tracked under CUSIP 13463J101.
  • 39 institutions reported positions in Q4 2025.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 28 to 39 between Q3 2025 and Q4 2025.
  • Reported value moved from $84,630,390 to $234,599,194.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 39 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 13463J101?
CUSIP 13463J101 identifies CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% $37,908,892 6,307,636 JANUS HENDERSON GROUP PLC 31 Dec 2025
5AM Ventures VI, L.P. 12% $8,392,800 5,869,091 Andrew J. Schwab 09 Sep 2025
FMR LLC 9.5% +40% $28,968,451 +$10,440,496 4,918,243 +56% FMR LLC 31 Dec 2025
Coastlands Capital LP 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
Polaris Management Co. VII, L.L.C. 8.4% $5,623,119 3,932,251 Amir Nashat 09 Sep 2025
Vivo Opportunity Fund Holdings, L.P. 7.4% -2.5% $23,373,365 +$1,788,900 3,856,991 +8.3% Vivo Opportunity Fund Holdings, L.P. 31 Dec 2025
Enavate Sciences GP, LLC 4.8% -20% $10,955,517 -$2,773,593 2,495,562 -20% Enavate Sciences GP, LLC 09 Mar 2026
Northpond Ventures II, LP 4.8% $6,714,732 2,238,244 Michael P. Rubin 30 Sep 2025
AH Bio Fund I, L.P. 4.5% $6,376,017 2,125,339 Marc L. Andreessen 30 Sep 2025
HARBOURVEST PARTNERS LLC 2.7% -60% $3,536,015 1,271,948 0% HarbourVest Partners L.P. 30 Sep 2025

As of 31 Dec 2025, 39 institutional investors reported holding 38,247,378 shares of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP). This represents 74% of the company’s total 51,990,875 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 12% 6,307,636 +36% 0.02% $38,807,475
5AM Venture Management, LLC 11% 5,869,091 0% 11% $35,977,528
FMR LLC 9.5% 4,918,243 +63% 0% $30,148,830
Vivo Capital, LLC 8.2% 4,246,568 +8.3% 1.7% $26,031,462
ENAVATE SCIENCES GP, LLC 5.8% 3,035,825 -20% 3.7% $18,609,607
Balyasny Asset Management L.P. 4.7% 2,436,900 0.03% $14,938,197
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.2% 2,181,679 +11% 0.02% $13,373,692
a16z Capital Management, L.L.C. 4.1% 2,125,339 0% 0.82% $13,028,328
Trails Edge Capital Partners, LP 3.8% 1,983,986 0% 3% $12,161,834
VANGUARD GROUP INC 3.2% 1,672,960 +434% 0% $10,255,245
HarbourVest Partners LLC 2.4% 1,271,948 0% 4.5% $7,797,041
BlackRock, Inc. 0.75% 390,160 +3311% 0% $2,391,681
GEODE CAPITAL MANAGEMENT, LLC 0.65% 336,293 +457% 0% $2,062,578
EcoR1 Capital, LLC 0.63% 325,000 0.09% $1,992,250
Stonepine Capital Management, LLC 0.44% 228,894 1.1% $1,403,120
Alyeska Investment Group, L.P. 0.38% 200,000 0% 0% $1,226,000
683 Capital Management, LLC 0.24% 126,363 0.06% $774,605
TWO SIGMA INVESTMENTS, LP 0.18% 94,531 -2.9% 0% $579,475
VICTORY CAPITAL MANAGEMENT INC 0.16% 82,790 0% 0% $507,503
NORTHERN TRUST CORP 0.14% 74,509 +410% 0% $456,740
BARCLAYS PLC 0.14% 73,601 +105044% 0% $451,174
STATE STREET CORP 0.08% 39,700 +53% 0% $243,361
ExodusPoint Capital Management, LP 0.07% 34,720 0% $212,834
JANE STREET GROUP, LLC 0.05% 25,534 0% $156,523
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.05% 25,000 0% 0% $153,250

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 38,247,378 $234,599,194 +$51,453,984 $6.13 39
2025 Q3 28,210,083 $84,630,390 +$49,505,803 $3.00 28
2025 Q2 11,744,129 $17,029,220 -$3,217,598 $1.45 28
2025 Q1 12,677,488 $50,710,355 -$1,002,366 $4.00 39
2024 Q4 12,854,057 $67,096,861 +$47,332,167 $5.22 36